Aspen Pharmacare (OTCMKTS:APNHY) Reaches New 12-Month High – Should You Buy?

Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $10.11 and last traded at $9.83, with a volume of 431 shares. The stock had previously closed at $9.63.

Aspen Pharmacare Price Performance

The company’s 50-day simple moving average is $9.56 and its 200 day simple moving average is $8.67. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.54 and a quick ratio of 1.68.

Aspen Pharmacare Company Profile

(Get Free Report)

Aspen Pharmacare Holdings Limited is a South African pharmaceutical company that develops, manufactures and supplies branded and generic medicines, consumer health products and active pharmaceutical ingredients. Its portfolio includes prescription and over-the-counter medicines, as well as products used in areas such as anesthetics, thrombosis, critical care and women’s health.

The company operates an international manufacturing and commercial network serving markets across Africa, Europe, Latin America, Asia and Australia.

Featured Stories

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.